Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Daily News

FDA Panel Declines to Endorse Ventura Interatrial Shunt for HFrEF

Todd Neale

December 05, 2025

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Daily News

Acute HF Patients Live Longer When Seen by Specialists

Michael O'Riordan

August 09, 2024

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Daily News

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

L.A. McKeown

February 12, 2024

News Daily News

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Michael O'Riordan

September 18, 2023

News Daily News

Takotsubo Trigger Type Matters, With Physical Shocks Linked to Worse Outcomes

Shelley Wood

July 19, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Daily News

One in Six COAPT Patients Had Malnutrition: TEER Helped Regardless

Shelley Wood

June 12, 2023

News Daily News

Monitoring PA Pressures With CardioMEMS May Help LVAD Patients

Todd Neale

April 27, 2023

News Daily News

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Michael O'Riordan

March 29, 2023

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Caitlin E. Cox

December 09, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Daily News

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

Shelley Wood

February 22, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Daily News

FDA: Another Class I Recall for HeartWare VAD

Shelley Wood

April 16, 2021

Advertisement

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

FDA Panel Declines to Endorse Ventura Interatrial Shunt for HFrEF

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Acute HF Patients Live Longer When Seen by Specialists

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Takotsubo Trigger Type Matters, With Physical Shocks Linked to Worse Outcomes

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

One in Six COAPT Patients Had Malnutrition: TEER Helped Regardless

Monitoring PA Pressures With CardioMEMS May Help LVAD Patients

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

FDA: Another Class I Recall for HeartWare VAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content